# Vera — Medtech Use Cases

**Last updated:** April 26, 2026

Vera is a runtime trust layer for AI agents in medtech. It sits between the agent and any consequential action, enforces policy, routes high-risk actions to a human approver, and cryptographically signs every decision.

Below: 7 concrete use cases across clinical, RCM, prior auth, pharma, and device workflows.

---

## 1. AI scribe → chart entry (clinical documentation)

**Customer**: Hospital system or clinic group deploying an AI scribe (Abridge, Ambience, Suki, DAX).

**Problem**: Scribes generate clinical notes that get pushed to the EHR. Hospitals are on the hook under HIPAA, Colorado AI Act, and CMS AI rules if a hallucinated diagnosis or wrong med list ends up in the chart. Today there's no enforced sign-off and no signed record of what the AI suggested vs. what the physician accepted.

**Flow**:
1. Scribe generates note suggesting *acute pancreatitis* with lab orders.
2. Vera intercepts before chart commit.
3. Policy: any new diagnosis or med order requires attending sign-off.
4. Vera routes to physician's slack/app/whatever they want to use — *Confirm / Modify / Reject*.
5. Physician modifies (removes one med), confirms.
6. Vera signs: original AI suggestion, physician edits, final accepted version, model version, timestamp.
7. Note enters chart. Signed log goes to compliance.

**Wedge**: hospital can finally deploy AI scribes in production without legal blocking the rollout.

---

## 2. Prior authorization agent (RCM)

**Customer**: Health system or RCM vendor using AI agents (Cohere Health, Anterior-style) to assemble and submit prior auths.

**Problem**: Agent picks codes, drafts medical necessity language, submits to payers. Wrong codes = denied claims, audit risk, potential False Claims Act exposure. No record of why the agent picked what it picked.

**Flow**:
1. Agent prepares prior auth for MRI with code 70553 + medical necessity narrative.
2. Vera policy: procedures with reimbursement > $2K require RCM lead review.
3. Routes to RCM lead with diff view: *agent suggested codes, narrative, supporting evidence*.
4. RCM lead approves (or edits codes, then approves).
5. Vera signs the full chain. Submission goes to payer.
6. If denied or audited later, the signed log shows exactly what the agent recommended, what the human approved, and why.

**Wedge**: RCM vendors can sell to hospitals with "every coding decision is human-approved and signed" as a contractual differentiator.

---

## 3. AI triage / symptom checker (telehealth)

**Customer**: Telehealth platform (Teladoc, Amwell, K Health-style) running an AI front-door for patient intake.

**Problem**: AI triages patients to self-care, virtual visit, urgent care, or ER. A wrong "self-care" call on a stroke or sepsis patient is a malpractice event. AB 316 already removed the "AI did it autonomously" defense in California.

**Flow**:
1. Patient describes symptoms. AI assesses, recommends *self-care, no escalation*.
2. Vera policy: any *no-escalation* output where symptom set includes red-flag terms (chest pain, sudden weakness, severe headache) requires nurse review before patient sees the recommendation.
3. Routes to on-call RN. RN reviews in <60 seconds, escalates to virtual visit.
4. Patient sees the escalated recommendation. AI's original suggestion never reaches them.
5. Vera signs the full decision chain.

**Wedge**: telehealth platform reduces malpractice exposure and gets a defensible record for every triage decision.

---

## 4. Clinical trial eligibility agent (pharma / CRO)

**Customer**: CRO or pharma sponsor using AI agents to screen patients for trial eligibility.

**Problem**: Agent scans EHR data against inclusion/exclusion criteria. Wrong eligibility decisions → enrolling ineligible patients (FDA inspection finding, potential trial integrity issue) or excluding eligible ones (slow enrollment, bias risk, IRB concerns).

**Flow**:
1. Agent reviews patient chart against Phase 3 oncology trial criteria, returns *eligible*.
2. Vera policy: every eligibility determination requires study coordinator review before consent outreach.
3. Coordinator reviews agent's reasoning + cited chart evidence in dashboard.
4. Coordinator approves or rejects with reason.
5. Vera signs. Eligible patient enters consent workflow.
6. At FDA inspection, sponsor produces signed log showing every eligibility decision was human-confirmed with citation trail.

**Wedge**: trial sponsors can use AI for screening (3–5x faster) without GCP audit risk.

---

## 5. Insurance claims denial / appeal agent

**Customer**: Provider-side appeals vendor or hospital revenue integrity team using AI to draft denial appeals.

**Problem**: AI agent reads denial letter, pulls chart evidence, drafts appeal. Submitting appeals with wrong patient info, fabricated citations, or unsupported clinical claims is a regulatory and reputational disaster.

**Flow**:
1. Agent drafts appeal for denied $40K cardiac procedure claim with cited clinical evidence.
2. Vera policy: any appeal > $10K requires utilization review nurse approval.
3. UR nurse sees agent's draft + evidence chain + diff against original chart.
4. Nurse approves (or edits citations, approves).
5. Appeal submits. Signed log retained.

**Wedge**: appeals vendors get to charge premium on the contingency-fee model because their accuracy is verifiable and audit-ready.

---

## 6. Pharmacovigilance / adverse event reporting

**Customer**: Mid-pharma or medical device company using AI agents to triage adverse event reports for FDA submission (E2B(R3), MedWatch, MDR/Vigilance).

**Problem**: AI classifies reports as serious / non-serious, codes them with MedDRA, drafts the ICSR. Wrong seriousness classification = late or missing 15-day reports = FDA Form 483 finding. FDA's Elsa is now agentically reviewing PV submissions and flagging inconsistencies.

**Flow**:
1. Agent ingests adverse event report. Classifies as *non-serious*. Codes with MedDRA term.
2. Vera policy: any classification of fatal, life-threatening, or hospitalization terms in source text → mandatory PV physician review regardless of agent's classification.
3. Source text includes "patient hospitalized for 4 days." Vera flags. Routes to PV physician.
4. Physician reclassifies as *serious / hospitalization*, triggers 15-day reportability.
5. Vera signs the override. Report submits on time.

**Wedge**: pharma can scale PV operations with AI without risking late reportability findings.

---

## 7. Physician credentialing / payer enrollment

**Customer**: Medical group or telehealth network with high physician churn, using AI to handle credentialing and payer enrollment workflows.

**Problem**: Agent files CAQH attestations, NPI updates, payer enrollment forms across 20+ payers per physician. Wrong DEA, wrong board-cert dates, missing malpractice coverage = denied claims for months and license-board risk.

**Flow**:
1. Agent assembles credentialing packet for new hire across CAQH + Medicare + 8 commercial payers.
2. Vera policy: every payer submission requires credentialing manager review of high-risk fields (DEA, board cert, malpractice carrier, sanctions check).
3. Manager reviews diff between agent extraction and source documents.
4. Approves submissions. Vera signs each.
5. If a payer later contests credentials, the signed chain proves what was submitted, when, and who approved it.

**Wedge**: high-churn medical groups (telehealth, locum, urgent care) cut credentialing time from 90 days to 30 without compliance risk.

---

## What's consistent across all 7 use cases

- **The AI does the work.** Vera doesn't replace agents; it makes them deployable in regulated workflows.
- **A human approves the consequential moves.** Approval surface is Slack / mobile / dashboard, designed for <60-second decisions.
- **Every action is cryptographically signed.** Tamper-evident, exportable, designed for FRE 901/902 admissibility (legal opinion in progress).
- **The buyer is platform engineering or compliance**, not the clinician using it.
- **Pricing scales with action volume**, not seats.

Across all 7, Vera is the same product. The policy YAML/JSON, the HITL routing, the signed log structure are identical. What changes is the policy ruleset and the integration target.

That's the unlock: one runtime trust layer, every regulated medtech use case, one signed-log dataset that becomes the underwriting feed for AI insurance in Act 2.